Seeking Alpha
Johnson & Johnson raises 2026 outlook to $11.30-$11.50 EPS and $100.2B sales midpoint while targeting $100B annual revenue
"We said 2026 would be a year of accelerated growth and impact for Johnson & Johnson. And with our strong Q1 performance, including our beat on consensus and raised guidance, you can see we are ...
USA Today
From Band-Aids to biotech, Johnson & Johnson became an American icon
Johnson & Johnson grew out of an 1876 lecture by Dr. Joseph Lister on the promising results seen in his new procedure, sterile surgery. Three brothers started Johnson & Johnson, finding a factory to ...